Richard Armer

Richard Armer joined Redx in 2012, becoming Chief Scientific Officer in 2014. He has significant experience in both small biotechnology and large pharmaceutical companies through his roles within Pfizer, Organon, Ardana, Oxagen, Lectus Therapeutics. Richard’s expertise is in drug discovery with a particular focus on lead optimization activities, drug disposition, intellectual property, and commercial scientific project positioning. He has experience across a wide range of therapeutic areas and has been successful in generating and progressing multiple clinical candidates.

Richard Armer is the CSO at Redx Pharma, based in United States, North America. With a background in Biotechnology, Richard Armer has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.